Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB26FZQ78
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $12,116
Award facts
- Contract value 100% obligated
- $12,115.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of JAKAFI 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on October 21, 2025, with an ultimate completion date of October 22, 2025, carries no set-aside designation, demonstrating the contractor's ability to compete effectively in unrestricted federal procurement. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group maintains its operations as a critical pharmaceutical supplier within the federal supply chain.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, designated as contract SPE2DR. The IDC, awarded on November 13, 2025, carries a ceiling value of $499,999,999 and extends through December 31, 2036, positioning the company as a regional prime vendor contractor within the broader $30.3 billion PPV-G GEN V acquisition strategy. Through this contract vehicle, DMS Pharmaceutical Group supplies a comprehensive range of pharmaceutical products—including branded and generic prescription medications, biologics, vaccines, and medical consumables—to support the Department of Defense's global military healthcare operations.
Quick answers
Who was awarded contract SPE2DB26FZQ78?
SPE2DB26FZQ78 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 21, 2025.
How much is contract SPE2DB26FZQ78 worth?
The government has obligated $12,116 on SPE2DB26FZQ78.
Is contract SPE2DB26FZQ78 an order under another contract?
Yes. SPE2DB26FZQ78 is a delivery order under SPE2DB22D9244, an indefinite delivery contract.
Was contract SPE2DB26FZQ78 competed?
The extent of competition for SPE2DB26FZQ78 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award